Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance Journal Article


Authors: Zamarin, D.; Devlin, S. M.; Arcila, M. E.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Weltz, J.; Babu, D.; Giralt, S.; Hassoun, H.
Article Title: Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance
Journal Title: Leukemia
Volume: 27
Issue: 12
ISSN: 0887-6924
Publisher: Nature Publishing Group  
Date Published: 2013-12-01
Start Page: 2422
End Page: 2424
Language: English
DOI: 10.1038/leu.2013.126
PROVIDER: scopus
PUBMED: 23608883
DOI/URL:
Notes: Export Date: 2 January 2014 -- CODEN: LEUKE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1070 Giralt
  2. Dmitriy Zamarin
    202 Zamarin
  3. Hani Hassoun
    339 Hassoun
  4. Heather Jolie Landau
    437 Landau
  5. Nikoletta Lendvai
    106 Lendvai
  6. Maria Eugenia Arcila
    673 Arcila
  7. Alexander Meyer Lesokhin
    381 Lesokhin
  8. David Chung
    250 Chung
  9. Sean McCarthy Devlin
    616 Devlin
  10. Jonathan Ian Weltz
    4 Weltz